Loading clinical trials...
Loading clinical trials...
Conditions
Locations
31
United States
Clinical Trial Site
Scottsdale, Arizona, United States
Clinical Trial Site
Tucson, Arizona, United States
Clinical Trial Site
Denver, Colorado, United States
Clinical Trial Site
Chicago, Illinois, United States
Clinical Trial Site
Indianapolis, Indiana, United States
Clinical Trial Site
Baltimore, Maryland, United States
Start Date
January 29, 2019
Primary Completion Date
May 18, 2020
Completion Date
May 18, 2020
Last Updated
June 16, 2020
NCT06192979
NCT07250269
NCT07052903
NCT07388602
NCT07359690
NCT07358078
Lead Sponsor
Alnylam Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions